|
1
|
Vieceli Dalla Sega F, Fortini F, Aquila G,
Campo G, Vaccarezza M and Rizzo P: Notch signaling regulates immune
responses in atherosclerosis. Front Immunol. 10:11302019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berman JW and Calderon TM: The role of
endothelial cell adhesion molecules in the development of
atherosclerosis. Cardiovasc Pathol. 1:17–28. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Geng J, Liu H, Ge P, Hu T, Zhang Y, Zhang
X, Xu B, Wang B and Xie J: PM2.5 promotes plaque vulnerability at
different stages of atherosclerosis and the formation of foam cells
via TLR4/MyD88/NFκB pathway. Ecotoxicol Environ Saf. 176:76–84.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McLaren JE, Michael DR, Ashlin TG and
Ramji DP: Cytokines, macrophage lipid metabolism and foam cells:
Implications for cardiovascular disease therapy. Prog Lipid Res.
50:331–347. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chistiakov DA, Bobryshev YV and Orekhov
AN: Macrophage-mediated cholesterol handling in atherosclerosis. J
Cell Mol Med. 20:17–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Finn AV, Kramer MC, Vorpahl M, Kolodgie FD
and Virmani R: Pharmacotherapy of coronary atherosclerosis. Expert
Opin Pharmacother. 10:1587–1603. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang H, Su X, Wu Q, Shan H, Lv L, Yu T,
Zhao X, Sun J, Yang R, Zhang L, et al: lncRNA 2810403D21Rik/Mirf
promotes ischemic myocardial injury by regulating autophagy through
targeting Mir26a. Autophagy. 12:1–15. 2019.(Epub ahead of print).
View Article : Google Scholar
|
|
8
|
Zhang M, Jiang Y, Guo X, Zhang B, Wu J,
Sun J, Liang H, Shan H, Zhang Y, Liu J, et al: Long non-coding RNA
cardiac hypertrophy-associated regulator governs cardiac
hypertrophy via regulating miR-20b and the downstream PTEN/AKT
pathway. J Cell Mol Med. 23:7685–7698. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu T, Wu D, Wu Q, Zou B, Huang X, Cheng X,
Wu Y, Hong K, Li P, Yang R, et al: Knockdown of long non-coding
RNA-ZFAS1 protects cardiomyocytes against acute myocardial
infarction via anti-apoptosis by regulating miR-150/CRP. J Cell
Biochem. 118:3281–3289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Uchida S and Dimmeler S: Long noncoding
RNAs in cardiovascular diseases. Circ Res. 116:737–750. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen L, Yang W, Guo Y, Chen W, Zheng P,
Zeng J and Tong W: Exosomal lncRNA GAS5 regulates the apoptosis of
macrophages and vascular endothelial cells in atherosclerosis. PLoS
One. 12:e01854062017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo FX, Wu Q, Li P, Zheng L, Ye S, Dai XY,
Kang CM, Lu JB, Xu BM, Xu YJ, et al: The role of the
lncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of
autophagy flux and inflammation through mTOR-dependent signaling.
Cell Death Differ. 26:1670–1687. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bayoumi AS, Sayed A, Broskova Z, Teoh JP,
Wilson J, Su H, Tang YL and Kim IM: Crosstalk between long
noncoding RNAs and MicroRNAs in health and disease. Int J Mol Sci.
17:3562016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee NK, Lee JH, Ivan C, Ling H, Zhang X,
Park CH, Calin GA and Lee SK: MALAT1 promoted invasiveness of
gastric adenocarcinoma. BMC Cancer. 17:462017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Malakar P, Shilo A, Mogilevsky A, Stein I,
Pikarsky E, Nevo Y, Benyamini H, Elgavish S, Zong X, Prasanth KV
and Karni R: Long noncoding RNA MALAT1 promotes hepatocellular
carcinoma development by SRSF1 upregulation and mTOR activation.
Cancer Res. 77:1155–1167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arslan S, Berkan Ö, Lalem T, Özbilüm N,
Göksel S, Korkmaz Ö, Çetin N and Devaux Y; Cardiolinc™ network, :
Long non-coding RNAs in the atherosclerotic plaque.
Atherosclerosis. 266:176–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cremer S, Michalik KM, Fischer A,
Pfisterer L, Jaé N, Winter C, Boon RA, Muhly-Reinholz M, John D,
Uchida S, et al: Hematopoietic deficiency of the long noncoding RNA
MALAT1 promotes atherosclerosis and plaque inflammation.
Circulation. 139:1320–1334. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moore KJ, Sheedy FJ and Fisher EA:
Macrophages in atherosclerosis: A dynamic balance. Nat Rev Immunol.
13:709–721. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tan L, Meng L, Shi X and Yu B: Knockdown
of microRNA-17-5p ameliorates atherosclerotic lesions in
ApoE−/− mice and restores the expression of very low
density lipoprotein receptor. Biotechnol Lett. 39:967–976. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao GJ, Mo ZC, Tang SL, Ouyang XP, He PP,
Lv YC, Yao F, Tan YL, Xie W, Shi JF, et al: Chlamydia pneumoniae
negatively regulates ABCA1 expression via TLR2-Nuclear factor-kappa
B and miR-33 pathways in THP-1 macrophage-derived foam cells.
Atherosclerosis. 235:519–525. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chinetti G, Lestavel S, Bocher V, Remaley
AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, et
al: PPAR-alpha and PPAR-gamma activators induce cholesterol removal
from human macrophage foam cells through stimulation of the ABCA1
pathway. Nat Med. 7:53–58. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie Z, Yuan Y, Shi J, Shi X, Gao X, Zhao
Y, Ye J and Feng X: Metformin inhibits THP-1 macrophage-derived
foam cell formation induced by lipopolysaccharide. Xi Bao Yu Fen Zi
Mian Yi Xue Za Zhi. 32:168–172. 2016.(In Chinese). PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Voloshyna I, Hai O, Littlefield MJ,
Carsons S and Reiss AB: Resveratrol mediates anti-atherogenic
effects on cholesterol flux in human macrophages and endothelium
via PPARg and adenosine. Eur J Pharmacol. 698:299–309. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu K, Huang J, Ni J, Song D, Ding M, Wang
J, Huang X and Li W: MALAT1 promotes osteosarcoma development by
regulation of HMGB1 via miR-142-3p and miR-129-5p. Cell Cycle.
16:578–587. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Okugawa Y, Toiyama Y, Hur K, Toden S,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR and
Goel A: Metastasis-associated long non-coding RNA drives gastric
cancer development and promotes peritoneal metastasis.
Carcinogenesis. 35:2731–2739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li S, Sun Y, Zhong L, Xiao Z, Yang M, Chen
M, Wang C, Xie X and Chen X: The suppression of ox-LDL-induced
inflammatory cytokine release and apoptosis of HCAECs by long
non-coding RNA-MALAT1 via regulating microRNA-155/SOCS1 pathway.
Nutr Metab Cardiovasc Dis. 28:1175–1187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fenyo IM and Gafencu AV: The involvement
of the monocytes/macrophages in chronic inflammation associated
with atherosclerosis. Immunobiology. 218:1376–1384. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kita T, Kume N, Minami M, Hayashida K,
Murayama T, Sano H, Moriwaki H, Kataoka H, Nishi E, Horiuchi H, et
al: Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci.
947:199–205; discussion 205-196. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin YW, Liu PS, Adhikari N, Hall JL and
Wei LN: RIP140 contributes to foam cell formation and
atherosclerosis by regulating cholesterol homeostasis in
macrophages. J Mol Cell Cardiol. 79:287–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Quinn MT, Parthasarathy S, Fong LG and
Steinberg D: Oxidatively modified low density lipoproteins: A
potential role in recruitment and retention of monocyte/macrophages
during atherogenesis. Proc Natl Acad Sci USA. 84:2995–2998. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Parthasarathy S, Quinn MT and Steinberg D:
Is oxidized low density lipoprotein involved in the recruitment and
retention of monocyte/macrophages in the artery wall during the
initiation of atherosclerosis? Basic Life Sci. 49:375–380.
1988.PubMed/NCBI
|
|
36
|
Mangum LC, Hou X, Borazjani A, Lee JH,
Ross MK and Crow JA: Silencing carboxylesterase 1 in human THP-1
macrophages perturbs genes regulated by PPARg/RXR and RAR/RXR:
Down-regulation of CYP27A1-LXRα signaling. Biochem J. 475:621–642.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pluddemann A, Neyen C and Gordon S:
Macrophage scavenger receptors and host-derived ligands. Methods.
43:207–217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Naito M, Suzuki H, Mori T, Matsumoto A,
Kodama T and Takahashi K: Coexpression of type I and type II human
macrophage scavenger receptors in macrophages of various organs and
foam cells in atherosclerotic lesions. Am J Pathol. 141:591–599.
1992.PubMed/NCBI
|
|
39
|
Mietus-Snyder M, Gowri MS and Pitas RE:
Class A scavenger receptor up-regulation in smooth muscle cells by
oxidized low density lipoprotein. Enhancement by calcium flux and
concurrent cyclooxygenase-2 up-regulation. J Biol Chem.
275:17661–17670. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Suzuki H, Kurihara Y, Takeya M, Kamada N,
Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, et
al: A role for macrophage scavenger receptors in atherosclerosis
and susceptibility to infection. Nature. 386:292–296. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rhainds D and Brissette L: The role of
scavenger receptor class B type I (SR-BI) in lipid trafficking.
Defining the rules for lipid traders. Int J Biochem Cell Biol.
36:39–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ren K, Jiang T, Zhou HF, Liang Y and Zhao
GJ: Apigenin retards atherogenesis by promoting ABCA1-mediated
cholesterol efflux and suppressing inflammation. Cell Physiol
Biochem. 47:2170–2184. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yoon JH, Abdelmohsen K and Gorospe M:
Functional interactions among microRNAs and long noncoding RNAs.
Semin Cell Dev Biol. 34:9–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tan L, Liu L, Jiang Z and Hao X:
Inhibition of microRNA-17-5p reduces the inflammation and lipid
accumulation, and up-regulates ATP-binding cassette transporterA1
in atherosclerosis. J Pharmacol Sci. 139:280–288. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang C, Yu XH, Zheng XL, Ou X and Tang
CK: Interferon-stimulated gene 15 promotes cholesterol efflux by
activating autophagy via the miR-17-5p/Beclin-1 pathway in THP-1
macrophage-derived foam cells. Eur J Pharmacol. 827:13–21. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tang XE, Li H, Chen LY, Xia XD, Zhao ZW,
Zheng XL, Zhao GJ and Tang CK: IL-8 negatively regulates ABCA1
expression and cholesterol efflux via upregulating miR-183 in THP-1
macrophage-derived foam cells. Cytokine. 122:1543852018. View Article : Google Scholar : PubMed/NCBI
|
